Expert Recap

Non-Hodgkin’s Lymphoma

Source: Non-Hodgkin’s Lymphoma*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Non-Hodgkin’s Lymphoma

CME Program Director: Roy A. Beveridge, MD

Faculty:
Julie M. Vose, MD

CME CREDIT INFORMATION

Release Date: 02/14/08

Expiration Date: 02/13/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Report recent data on the use of bortezomib in the treatment of mantle cell lymphoma
Summarize new treatment strategies for consolidation of follicular lymphoma
Describe the activity of rituximab in the treatment of lymphocyte-predominant Hodgkin’s disease
Discuss the role of prophylactic cranial irradiation in the treatment of aggressive non-Hodgkin’s lymphoma with bone marrow involvement

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.